Evidence map›Paper›PMID 26967158›Full record

ArticlePloS one2016

Multicentre Double-Blind Placebo-Controlled Food Challenge Study in Children Sensitised to Cashew Nut.

Johanna P M van der Valk, Roy Gerth van Wijk, Anthony E J Dubois, Hans de Groot, Marit Reitsma, Berber Vlieg-Boerstra, Huub F J Savelkoul, Harry J Wichers, Nicolette W de Jong

Registry-linked trialOpen access · goldAbstract readMulticenter Study
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07158619 (Evaluation of the Acquisition of Sustained Unresponsiveness to Cashew Nut Protein Following Oral Allergen-Specific Immunotherapy - Long-Term Follow-Up of Patients From the RCT "Efficacy of Cashew Nut Protein Immunotherapy), which is not on this map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07158619 nanot yet recruitingnot on this mapstarted 2025, after this paper: background citation

Evaluation of the Acquisition of Sustained Unresponsiveness to Cashew Nut Protein Following Oral Allergen-Specific Immunotherapy - Long-Term Follow-Up of Patients From the RCT "Efficacy of Cashew Nut Protein Immunotherapy: A Protocol of a Single-Center Randomized Controlled Trial in the Pediatric Population" (NCT06328504)

TypeinterventionalSponsorMedical University of WarsawRan2025 to 2029Enrolled39ConditionsFood Allergy in ChildrenArmsOIT with cashew nut protein
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Identification and in silico bioinformatics analysis of PR10 proteins in cashew nut.Protein science : a publication of the Protein Society · 2020
    Article
  13. Article
  14. Cashew Nut Allergy: Clinical Relevance and Allergen Characterisation.Clinical reviews in allergy & immunology · 2019
    Review
  15. Article
  16. Innovation in Food Challenge Tests for Food Allergy.Current allergy and asthma reports · 2018
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Johanna P M van der ValkDepartment Of Internal Medicine, Allergology, Erasmus MC, Rotterdam, the Netherlands.
Roy Gerth van WijkDepartment Of Internal Medicine, Allergology, Erasmus MC, Rotterdam, the Netherlands.
Anthony E J DuboisDepartment of Pediatric Pulmonology and Pediatric Allergology, University Medical Centre Groningen, GRIAC Research Institute, University of Groningen, Groningen, the Netherlands.
Hans de GrootDepartment of Pediatric Allergology, Diaconessenhuis Voorburg, RdGG, Delft, the Netherlands.
Marit ReitsmaFood and Biobased Research, Wageningen University and Research Centre, Wageningen, the Netherlands.
Berber Vlieg-BoerstraEmma Children's Hospital, Pediatric Respiratory Medicine and Allergy, Academic Medical Centre, University of Amsterdam, Amsterdam, the Netherlands.
Huub F J SavelkoulLaboratory of Cell Biology and Immunology, Wageningen University and Research Centre, Wageningen, the Netherlands.
Harry J WichersFood and Biobased Research, Wageningen University and Research Centre, Wageningen, the Netherlands.
Nicolette W de JongDepartment Of Internal Medicine, Allergology, Erasmus MC, Rotterdam, the Netherlands.
Wageningen University & Research · NLErasmus MC · NLDiakonessenhuis hospital · NLEmma Kinderziekenhuis · NLErasmus University Rotterdam · NLUniversity of Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFew studies with a limited number of patients have provided indications that cashew-allergic patients may experience severe allergic reactions to minimal amounts of cashew nut. The objectives of this multicentre study were to assess the clinical relevance of cashew nut sensitisation, to study the clinical reaction patterns in double-blind placebo-controlled food challenge tests and to establish the amount of cashew nuts that can elicit an allergic reaction. METHODS AND

findingsA total of 179 children were included (median age 9.0 years; range 2-17 years) with cashew nut sensitisation and a clinical history of reactions to cashew nuts or unknown exposure. Sensitised children who could tolerate cashew nuts were excluded. The study included three clinical visits and a telephone consultation. During the first visit, the medical history was evaluated, physical examinations were conducted, blood samples were drawn and skin prick tests were performed. The children underwent a double-blind placebo-controlled food challenge test with cashew nut during the second and third visits. The study showed that 137 (76.5%) of the sensitised children suspected of allergy to cashew nut had a positive double-blind placebo-controlled food challenge test, with 46% (63) manifesting subjective symptoms to the lowest dose of 1 mg cashew nut protein and 11% (15) developing objective symptoms to the lowest dose. Children most frequently had gastro-intestinal symptoms, followed by oral allergy and skin symptoms. A total of 36% (49/137) of the children experienced an anaphylactic reaction and 6% (8/137) of the children were treated with epinephrine.

conclusionThis prospective study demonstrated a strikingly high percentage of clinical reactions to cashew nut in this third line population. Severe allergic reactions, including anaphylaxis requiring epinephrine, were observed. These reactions were to minimal amounts of cashew nut, demonstrated the high potency of this allergens.

trial registrationwww.ncbi.nlm.nih.gov/pubmed NTR3572.

Indexed as

AdolescentAnacardiumAnaphylaxisChildChild, PreschoolDesensitization, ImmunologicDouble-Blind MethodEpinephrineFemaleHumansMaleNut HypersensitivitySkin TestsEpinephrine

Identifiers

PMID26967158
PMCPMC4788393
OpenAlexW2293552389

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.